PP
ABCL icon

Pacifica Partners’s AbCellera Biologics ABCL Stock Holding History

Pacifica Partners’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Sell
2,230
-400
-15% -$1.96K 0.01% 262
2026
Q1 		$9.18K Sell
2,630
-3,799
-59% -$13.7K ﹤0.01% 323
2025
Q4 		$22.1K Hold
6,429
– – 0.01% 239
2025
Q3 		$38.3K Sell
6,429
-900
-12% -$3.97K 0.01% 221
2025
Q2 		$26.5K Sell
7,329
-290
-4% -$722 0.01% 248
2025
Q1 		$15.8K Hold
7,619
– – 0.01% 300
2024
Q4 		$23K Hold
7,619
– – 0.01% 267
2024
Q3 		$19.8K Hold
7,619
– – 0.01% 297
2024
Q2 		$20.6K Sell
7,619
-1,000
-12% -$3.78K 0.01% 296
2024
Q1 		$39.4K Buy
8,619
+3,799
+79% +$19.4K 0.02% 231
2023
Q4 		$21.6K Buy
4,820
+2,185
+83% +$10.1K 0.01% 297
2023
Q3 		$11.6K Hold
2,635
– – 0.01% 327
2023
Q2 		$17.2K Hold
2,635
– – 0.01% 251
2023
Q1 		$19K Hold
2,635
– – 0.01% 250
2022
Q4 		$25K Hold
2,635
– – 0.02% 210
2022
Q3 		$28K Hold
2,635
– – 0.02% 202
2022
Q2 		$27K Buy
2,635
+230
+10% +$1.95K 0.02% 215
2022
Q1 		$23K Hold
2,405
– – 0.02% 226
2021
Q4 		$29K Hold
2,405
– – 0.02% 215
2021
Q3 		$51K Buy
2,405
+760
+46% +$13.4K 0.04% 154
2021
Q2 		$33K Buy
1,645
+1,600
+3,556% +$44.1K 0.03% 176
2021
Q1 		$1K Hold
45
– – ﹤0.01% 388
2020
Q4 		$2K Buy
+45
New +$2.06K ﹤0.01% 339

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Pacifica Partners's ABCL Position: Q2 2026 in Review

Pacifica Partners reduced its AbCellera Biologics (ABCL) stake by 15% in Q2 2026, selling an estimated $1.96K and leaving 2,230 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #262.

Pacifica Partners first reported a position in ABCL in Q4 2020 and has held it in 23 quarters since. The position peaked at $51K in Q3 2021. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Pacifica Partners held 2,230 shares of AbCellera Biologics worth $18.1K as of Q2 2026.
  • Pacifica Partners sold 400 AbCellera Biologics shares in Q2 2026, an estimated $1.96K.
  • AbCellera Biologics made up 0.01% of Pacifica Partners's portfolio in Q2 2026, its #262 holding.
  • Pacifica Partners first reported a position in AbCellera Biologics in Q4 2020 and has held it in 23 quarters since.
  • Pacifica Partners's AbCellera Biologics position peaked at $51K in Q3 2021.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.